Epilepsy Research
Volume 88, Issue 2 , Pages 145-150 , February 2010

Carbamazepine but not pregabalin impairs eye control: A study on acute objective CNS side effects in healthy volunteers

Received 10 August 2009 ,Revised 23 September 2009 ,Accepted 18 October 2009.

References 

  1. Anonymous . Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Collaborative Group for Epidemiology of Epilepsy. Epilepsia. 1986;27:323–330
  2. Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose–response study in adults with partial seizures. Epilepsia. 2004;45:20–27
  3. Bittencourt PR, Gresty MA, Richens A. Quantitative assessment of smooth-pursuit eye movements in healthy and epileptic subjects. J. Neurol. Neurosurg. Psychiatry. 1980;43:1119–1124
  4. Bittencourt PR, Wade P, Smith AT, Richens A. The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentrations. Br. J. Clin. Pharm. 1981;12:523–533
  5. Brandt C, May T, Pohlmann-Eden B, Nieder E, Elsner H, Witte-Boelt K, et al. Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients. Seizure. 2009;
  6. Brandt T. Vertigo: Its Multisensory Syndromes. London: Springer; 1991;
  7. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007;68:402–408
  8. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet. 1995;345:476–479
  9. Buttner U, Grundei T. Gaze-evoked nystagmus and smooth pursuit deficits: their relationship studied in 52 patients. J. Neurol. 1995;242:384–389
  10. Cohen AF, Ashby L, Crowly D, Land G, Peck AW, Miller AA. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br. J. Clin. Pharm. 1985;20:619–629
  11. Dieterich M, Straube A, Brandt T, Paulus W, Buttner U. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J. Neurol. Neurosurg. Psychiatry. 1991;54:627–632
  12. Ditterich, J., 1995. Untersuchung in die Sakkadensteuerung involvierter Gehirnstrukturen mittles Computertools. Thesis. Technical University of Munich, Munich.
  13. Dybdal D, Gale K. Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus. J. Neurosci. 2000;20:6728–6733
  14. Errante LD, Petroff OA. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure. 2003;12:300–306
  15. Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, et al. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. U.S.A. 2006;103:17537–17542
  16. Hamandi K, Sander JW. Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure. 2006;12:73–78
  17. Hamilton MJ, Cohen AF, Zuen AWC, Harkin N, Land G, Weatherley BC, et al. Carbamazepine and lamotrigine in healthy volunteers: relevance of early tolerance and clinical trial dosage. Epilepsia. 1993;34:166–173
  18. Kim KH, Ha JH, Chung SH, Kim CT, Kim SK, Hyun BH, et al. Glutamate and GABA concentrations in the cerebellum of novel ataxic mutant Pogo mice. J. Vet. Sci. 2003;4:209–212
  19. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N. Engl. J. Med. 2000;342:314–319
  20. Leigh RJ, Zee D. The Neurology of Eye Movement. Philadelphia: Davis; 1991;
  21. Leisman G, Schwartz J. Ocular-motor function and information processing: implications for the reading process. Int. J. Neurosci. 1977;8:7–15
  22. Levy RH, Pitlick WH, Troupin AS, Green JR, Neal JM. Pharmacokinetics of carbamazepine in normal man. Clin. Pharmacol. Ther. 1975;17:657–668
  23. May TW, Rambeck B, Neb R, Jurgens U. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication. Ther. Drug. Monit. 2007;29:789–794
  24. Messenheimer J, Ramsay RE, Willmore LJ, Leroy RF, Zielinski JJ, Mattson R, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia. 1994;35:113–121
  25. Noachtar S, von Maydell B, Fuhry L, Buttner U. Gabapentin and carbamazepine affect eye movements and posture control differently: a placebo-controlled investigation of acute CNS side effects in healthy volunteers. Epilepsy Res. 1998;31:47–57
  26. Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT, Weisler R, et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am. J. Psychiatry. 2003;160:533–540
  27. Paulus WM, Straube A, Brandt T. Visual stabilization of posture. Physiological stimulus characteristics and clinical aspects. Brain. 1984;107:1143–1163
  28. Remler BF, Leigh RJ, Osorio I, Tomsak RL. The characteristics and mechanisms of visual disturbance associated with anticonvulsant therapy. Neurology. 1990;40:791–796
  29. Salinsky M, Oken B, Binder L. Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy. Epilepsia. 1996;37:181–187
  30. Takeuchi Y, Takasu K, Ono H, Tanabe M. Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model. Neuropharmacology. 2007;53:842–853
  31. Tedeschi G, Casucci G, Allocca S, Riva R, Di Costanzo A, Tata MR, et al. Neuroocular side effects of carbamazepine and phenobarbital in epileptic patients as measured by saccadic eye movements analysis. Epilepsia. 1989;30:62–66
  32. Umeda Y, Sakata E. Equilibrium disorder in carbamazepine toxicity. Ann. Otol. Rhinol. Laryngol. 1977;86:318–322
  33. Vranken JH, Dijkgraaf MG, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008;136:150–157
  34. Wheeler SD, Ramsay RE, Weiss J. Drug-induced downbeat nystagmus. Ann. Neurol. 1982;12:227–228

PII: S0920-1211(09)00295-2

doi: 10.1016/j.eplepsyres.2009.10.007

Epilepsy Research
Volume 88, Issue 2 , Pages 145-150 , February 2010

Article Tools

* Image Usage & Resolution